Sanofi buys Kymab for up to $1.5 billion to expand in immunotherapy January 11, 2021 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Week Ahead: Stocks To Keep Rising As More Stimulus Seen; Bitcoin, Tesla To Soar Back: All Posts Next:European Stocks Slip; Consolidating as Covid Cases Rise